IL318676A - Cyclic peptide derivative, method for producing same and composition - Google Patents

Cyclic peptide derivative, method for producing same and composition

Info

Publication number
IL318676A
IL318676A IL318676A IL31867625A IL318676A IL 318676 A IL318676 A IL 318676A IL 318676 A IL318676 A IL 318676A IL 31867625 A IL31867625 A IL 31867625A IL 318676 A IL318676 A IL 318676A
Authority
IL
Israel
Prior art keywords
composition
cyclic peptide
producing same
peptide derivative
derivative
Prior art date
Application number
IL318676A
Other languages
English (en)
Hebrew (he)
Inventor
Kohei Matsumoto
Yuma Karita
Kosuke Yasui
Shichidai TANABE
Takeshi Shosu
Original Assignee
Dks Co Ltd
Kohei Matsumoto
Yuma Karita
Kosuke Yasui
Shichidai TANABE
Takeshi Shosu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dks Co Ltd, Kohei Matsumoto, Yuma Karita, Kosuke Yasui, Shichidai TANABE, Takeshi Shosu filed Critical Dks Co Ltd
Publication of IL318676A publication Critical patent/IL318676A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/12Cyclic peptides with only normal peptide bonds in the ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06078Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0812Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1016Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0618Cells of the nervous system
    • C12N5/0622Glial cells, e.g. astrocytes, oligodendrocytes; Schwann cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL318676A 2022-08-04 2023-08-04 Cyclic peptide derivative, method for producing same and composition IL318676A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2022124810 2022-08-04
JP2022159060 2022-09-30
PCT/JP2023/028632 WO2024029630A1 (ja) 2022-08-04 2023-08-04 環状ペプチド誘導体とその製造方法および組成物

Publications (1)

Publication Number Publication Date
IL318676A true IL318676A (en) 2025-03-01

Family

ID=89849507

Family Applications (1)

Application Number Title Priority Date Filing Date
IL318676A IL318676A (en) 2022-08-04 2023-08-04 Cyclic peptide derivative, method for producing same and composition

Country Status (12)

Country Link
US (1) US20260035407A1 (https=)
EP (1) EP4567042A1 (https=)
JP (1) JPWO2024029630A1 (https=)
KR (1) KR20250044905A (https=)
CN (1) CN119731193A (https=)
AU (1) AU2023317392A1 (https=)
CO (1) CO2025001948A2 (https=)
IL (1) IL318676A (https=)
MX (1) MX2025001373A (https=)
PE (1) PE20250797A1 (https=)
TW (1) TW202423948A (https=)
WO (1) WO2024029630A1 (https=)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172896A (en) 1978-06-05 1979-10-30 Dainippon Pharmaceutical Co., Ltd. Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same
GB9217295D0 (en) 1992-08-14 1992-09-30 Wellcome Found Controlled released tablets
US5541231A (en) 1993-07-30 1996-07-30 Glaxo Wellcome Inc. Stabilized Pharmaceutical
GB9315856D0 (en) 1993-07-30 1993-09-15 Wellcome Found Stabilized pharmaceutical
US5358970A (en) 1993-08-12 1994-10-25 Burroughs Wellcome Co. Pharmaceutical composition containing bupropion hydrochloride and a stabilizer
DE69839355T2 (de) 1997-07-29 2009-06-04 Alcon Laboratories, Inc., Fort Worth Ophthalmische Zusammensetzungen enthaltend Galaktomannanpolymere und Borat
AU2483599A (en) 1998-01-29 1999-08-16 Sepracor, Inc. Pharmaceutical uses of optically pure (-)-bupropion
US8889112B2 (en) 1999-09-16 2014-11-18 Ocularis Pharma, Llc Ophthalmic formulations including selective alpha 1 antagonists
US6933289B2 (en) 2003-07-01 2005-08-23 Allergan, Inc. Inhibition of irritating side effects associated with use of a topical ophthalmic medication
EP1654002B2 (en) 2003-08-07 2014-01-29 Allergan, Inc. Compositions for delivery of therapeutics into the eyes
US20050059744A1 (en) 2003-09-12 2005-03-17 Allergan, Inc. Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions
WO2016047638A1 (ja) * 2014-09-24 2016-03-31 国立大学法人岩手大学 環状ペプチド誘導体とその製造方法および組成物
JP7486328B2 (ja) * 2020-03-05 2024-05-17 株式会社バイオコクーン研究所 神経突起伸長促進剤、神経細胞の樹状突起発現促進剤、及び神経栄養因子様作用物質
JP7695662B2 (ja) * 2020-11-02 2025-06-19 公立大学法人大阪 環状ペプチド誘導体の製造方法及び環状ペプチド化合物の製造方法

Also Published As

Publication number Publication date
MX2025001373A (es) 2025-03-07
CN119731193A (zh) 2025-03-28
JPWO2024029630A1 (https=) 2024-02-08
KR20250044905A (ko) 2025-04-01
PE20250797A1 (es) 2025-03-14
AU2023317392A9 (en) 2026-02-12
US20260035407A1 (en) 2026-02-05
TW202423948A (zh) 2024-06-16
WO2024029630A1 (ja) 2024-02-08
CO2025001948A2 (es) 2025-03-06
EP4567042A1 (en) 2025-06-11
AU2023317392A1 (en) 2025-02-20

Similar Documents

Publication Publication Date Title
HUE073283T2 (hu) Heteroaril-származék, eljárás annak elõállítására és azt hatóanyagként tartalmazó gyógyászati készítmény
EP4026906A4 (en) TRANSLATION COMPOSITION AND METHOD FOR PRODUCING PEPTIDE
EP4144754A4 (en) ALLULOSE EPIMERASE VARIANT, METHOD FOR PRODUCING SAME AND METHOD FOR PRODUCING ALLULOSE USING SAME
EP4289802A4 (en) GLASS COMPOSITION AND GLASS FILLER AND METHOD FOR THE PRODUCTION THEREOF
EP4190338A4 (en) COMPOSITION COMPRISING EXOSOMES DERIVED FROM STEM CELLS AND METHOD OF PRODUCTION THEREOF
EP4389799A4 (en) FURANDIC ACID-BASED POLYAMIDE, PRODUCTION PROCESS THEREOF AND FURANDIC ACID-BASED POLYAMIDE COMPOSITION
EP4095232A4 (en) BACTERIA, COMPOSITION AND PRODUCTION METHOD THEREFOR, AND COMPOSITION OF PREBIOTICS
EP4039103A4 (en) COMPOSITION AND PRODUCTION PROCESS THEREOF
EP3978660A4 (en) STRUCTURAL PROTEIN MICROBODY AND METHOD FOR PRODUCTION THEREOF, NANOFIBER PRODUCTION METHOD AND PROTEIN STRUCTURE PRODUCTION METHOD
GB2608725B (en) Method for producing perovskite compound, and perovskite compound
EP4108706A4 (en) PROCESS FOR PRODUCING A CYCLIC POLYSILOXANE
IL318676A (en) Cyclic peptide derivative, method for producing same and composition
CA3264064A1 (en) Cyclic peptide derivative, method for producing same, and composition
AU2021377857A9 (en) Method for producing 4-borono-l-phenylalanine and intermediate thereof
EP4155365A4 (en) LUMINOPHOR COMPOSITION AND PRODUCTION METHOD THEREFOR
KR102887469B9 (ko) 저어분 넙치 양식용 사료 조성물, 이의 제조방법 및 이를 이용한 넙치 양식방법
PL4344710T3 (pl) Kompozyt, sposób jego otrzymywania oraz kompozycja wypełniacza, w której wykorzystuje się ten kompozyt do zabiegów chirurgii kosmetycznej
EP4310061A4 (en) GLASS COMPOSITION AND METHOD FOR PRODUCING A GLASS COMPOSITION
EP4053271A4 (en) NEW DEOXYGUANOSINE TRIPHOSPHATE TRIPHOSPHOHYDROLASE VARIANT, AND METHOD FOR PRODUCING L-TRYPTOPHANE USING THE SAME
EP4282873A4 (en) METHOD FOR SCREENING DIMERIZED CYCLIC PEPTIDES
ZA202205099B (en) Method for producing collagen peptides from bones, and produced collagen peptides
EP4219611A4 (en) ELASTOMER COMPOSITION, SEALING MATERIAL AND METHOD FOR PRODUCING A SEALING MATERIAL
EP4101636A4 (en) COMPOSITION FOR FORMING A GAS BARRIER FILM, GAS BARRIER FILM AND METHOD FOR THE PRODUCTION THEREOF
CA3287159A1 (en) Method for producing cyclic peptide compound
EP3998247A4 (en) COMPOST AND METHODS OF MAKING COMPOST